Home › Trial NCT01184274
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia
- Trial IDNCT01184274
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorNCIC Clinical Trials Group
- Enrollment12
- Start date2010-10-01
- ConditionsLeukemia · Solid Tumours
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.